Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.Richard W. Joseph, Richard Kefford, Omid Hamid et al.|Journal of Clinical Oncology|2015Cited by 6
3344 Relationship between pembrolizumab exposure and efficacy/safety in 1016 patients (pts) with advanced or metastatic melanomaSoonmo Peter Kang, Anna Kondic, Manash Chatterjee et al.|European Journal of Cancer|2015Cited by 3